Literature DB >> 21785869

Tumor budding and dedifferentiation in gallbladder carcinoma: potential for the prognostic factors in T2 lesions.

Keita Kai1, Naohiko Kohya, Kenji Kitahara, Masanori Masuda, Atsushi Miyoshi, Takao Ide, Osamu Tokunaga, Kohji Miyazaki, Hirokazu Noshiro.   

Abstract

Dedifferentiation (DD) is often encountered in gallbladder carcinoma (GBC) and poor prognosis with budding (BD) has been reported for other malignancies. However, the features of DD and BD in GBC remain unclear. The purpose of this study was to clarify the features and prognostic potential of DD and BD in GBC. A total of 80 patients with GBC (excluding intramucosal cancer) were enrolled. DD was histopathologically evaluated as tumors in which the grade of the invasive front is higher than the grade at the surface. BD was defined as an isolated single cancer cell or a cluster of fewer than five cancer cells at the invasive front. Of the 80 patients, 47 (58.8%) were positive for BD and 33 (41.2%) were positive for DD. Both BD and DD correlated significantly with disease-specific survival in univariate analysis (P < 0.0001 and P = 0.0013, respectively), but they were not identified as independent prognostic factors by multivariate analysis. In univariate analysis according to T stage, both BD and DD correlated significantly with survival in patients with T2 (n = 32) tumor (P = 0.0011 and P = 0.0018, respectively), whereas no prognostic impact in patients with T1b (n = 8), T3 (n = 34), or T4 (n = 6) tumor. Both DD and BD are frequently observed in GBC and reflect prognosis, particularly for T2 lesions. Therefore, the status of BD and DD should be taken into consideration in pathological reports on GBC.

Entities:  

Mesh:

Year:  2011        PMID: 21785869     DOI: 10.1007/s00428-011-1131-9

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  32 in total

1.  Radical resection improves survival for patients with pT2 gallbladder carcinoma.

Authors:  P E Wise; Y Y Shi; M K Washington; W C Chapman; J K Wright; K W Sharp; C W Pinson
Journal:  Am Surg       Date:  2001-11       Impact factor: 0.688

2.  Rational therapeutic strategy for T2 gallbladder carcinoma based on tumor spread.

Authors:  Naohiko Kohya; Kenji Kitahara; Kohji Miyazaki
Journal:  World J Gastroenterol       Date:  2010-07-28       Impact factor: 5.742

3.  Tumour 'budding' as an index to estimate the potential of aggressiveness in rectal cancer.

Authors:  H Ueno; J Murphy; J R Jass; H Mochizuki; I C Talbot
Journal:  Histopathology       Date:  2002-02       Impact factor: 5.087

Review 4.  Long-term results after resection for gallbladder cancer. Implications for staging and management.

Authors:  D L Bartlett; Y Fong; J G Fortner; M F Brennan; L H Blumgart
Journal:  Ann Surg       Date:  1996-11       Impact factor: 12.969

5.  Clinicopathological study of depth of subserosal invasion in patients with pT2 gallbladder carcinoma.

Authors:  Ryoko Sasaki; Noriyuki Uesugi; Hidenori Itabashi; Tomohiro Fujita; Yuichiro Takeda; Koichi Hoshikawa; Masahiro Takahashi; Osamu Funato; Hiroyuki Nitta; Tamotsu Sugai; Senji Kanno; Kazuyoshi Saito
Journal:  J Surg Oncol       Date:  2005-11-01       Impact factor: 3.454

6.  Tumour budding and a low host inflammatory response are associated with a poor prognosis in oesophageal and gastro-oesophageal junction cancers.

Authors:  Matthew Brown; Karim Sillah; Ewen A Griffiths; Ric Swindell; Catherine M West; Richard D Page; Ian M Welch; Susan A Pritchard
Journal:  Histopathology       Date:  2010-06       Impact factor: 5.087

7.  Primary carcinoma of the gallbladder: operative experience during a 16 year period.

Authors:  D Oertli; U Herzog; P Tondelli
Journal:  Eur J Surg       Date:  1993-08

8.  Prognostic value of tumor "budding" in patients with colorectal cancer.

Authors:  K Hase; C Shatney; D Johnson; M Trollope; M Vierra
Journal:  Dis Colon Rectum       Date:  1993-07       Impact factor: 4.585

9.  Multivariate analysis of the pathologic features of esophageal squamous cell cancer: tumor budding is a significant independent prognostic factor.

Authors:  Masahiko Koike; Yasuhiro Kodera; Yuichi Itoh; Goro Nakayama; Michitaka Fujiwara; Nobuyuki Hamajima; Akimasa Nakao
Journal:  Ann Surg Oncol       Date:  2008-04-12       Impact factor: 5.344

10.  Hepatectomy of segment 4a and 5 combined with extra-hepatic bile duct resection for T2 and T3 gallbladder carcinoma.

Authors:  Naohiko Kohya; Kohji Miyazaki
Journal:  J Surg Oncol       Date:  2008-05-01       Impact factor: 3.454

View more
  11 in total

Review 1.  Key factors influencing prognosis in relation to gallbladder cancer.

Authors:  Charles Henry Caldow Pilgrim; Ryan T Groeschl; Kiran K Turaga; T Clark Gamblin
Journal:  Dig Dis Sci       Date:  2013-05-22       Impact factor: 3.199

2.  Clinicopathologic features of advanced gallbladder cancer associated with adenomyomatosis.

Authors:  Keita Kai; Takao Ide; Masanori Masuda; Kenji Kitahara; Atsushi Miyoshi; Kohji Miyazaki; Hirokazu Noshiro; Osamu Tokunaga
Journal:  Virchows Arch       Date:  2011-10-26       Impact factor: 4.064

Review 3.  Tumour budding in solid cancers.

Authors:  Alessandro Lugli; Inti Zlobec; Martin D Berger; Richard Kirsch; Iris D Nagtegaal
Journal:  Nat Rev Clin Oncol       Date:  2020-09-08       Impact factor: 66.675

4.  Prognostic value of tumor budding in gallbladder cancer: application of the International Tumor Budding Consensus Conference scoring system.

Authors:  Han-Na Kim; Soo Yeon Lee; Baek-Hui Kim; Chung-Yeul Kim; Aeree Kim; Hayeon Kim
Journal:  Virchows Arch       Date:  2021-01-04       Impact factor: 4.064

5.  Adjuvant treatment in biliary tract cancer: to treat or not to treat?

Authors:  Stefano Cereda; Carmen Belli; Michele Reni
Journal:  World J Gastroenterol       Date:  2012-06-07       Impact factor: 5.742

Review 6.  Gallbladder cancer: Clinical and pathological approach.

Authors:  Keita Kai; Shinichi Aishima; Kohji Miyazaki
Journal:  World J Clin Cases       Date:  2014-10-16       Impact factor: 1.337

7.  High tumor budding predicts a poor prognosis in resected duodenal adenocarcinoma.

Authors:  Tatsuma Sakaguchi; Sohei Satoi; Daisuke Hashimoto; Tomohisa Yamamoto; So Yamaki; Satoshi Hirooka; Mitsuaki Ishida; Tsukasa Ikeura; Kentaro Inoue; Makoto Naganuma; Hideki Ishikawa; Mitsugu Sekimoto
Journal:  Surg Today       Date:  2022-01-06       Impact factor: 2.549

Review 8.  Tumor Budding: The Name is EMT. Partial EMT.

Authors:  Alexandru Dan Grigore; Mohit Kumar Jolly; Dongya Jia; Mary C Farach-Carson; Herbert Levine
Journal:  J Clin Med       Date:  2016-04-29       Impact factor: 4.241

9.  Inverse correlation between CD8+ inflammatory cells and E-cadherin expression in gallbladder cancer: Tissue microarray and imaging analysis.

Authors:  Keita Kai; Masanori Masuda; Shinichi Aishima
Journal:  World J Clin Cases       Date:  2017-01-16       Impact factor: 1.337

10.  Potential key roles of tumour budding: a representative malignant pathological feature of non-small cell lung cancer and a sensitive indicator of prognosis.

Authors:  Li Qian; Jianguo Zhang; Shumin Lu; Xin He; Jia Feng; Jiahai Shi; Yifei Liu
Journal:  BMJ Open       Date:  2022-03-31       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.